RESUMEN

To prospectively study systemic in vivo immunological effects of sex hormones, using different phases of oral combined hormonal contraceptives (CHC), and the natural menstrual cycles in both healthy women and in women with multiple sclerosis (MS), blood samples from sixty female MS patients and healthy controls with and without CHC were drawn in high and low estrogenic/progestogenic phases. Expression of Th-associated genes in blood cells was determined by qPCR and a panel of cytokines and chemokines was measured in plasma. High hormone level phases were associated with increases in Th1 (TBX21) and Th2 (GATA3) associated markers, as well as the B cell-associated chemokine CXCL13, while the inhibitory regulator CTLA-4 was decreased. These changes were not observed in MS patients, of whom most were treated with immunomodulatory drugs. Our data indicate immune activating properties in vivo of high steroid sex hormone levels during both CHC and normal menstrual cyclicity.

Asunto(s)

Linfocitos B/inmunología , Anticonceptivos Orales/administración & dosificación , Hormonas Esteroides Gonadales/metabolismo , Ciclo Menstrual/inmunología , Esclerosis Múltiple/inmunología , Células TH1/inmunología , Células Th2/inmunología , Adolescente , Adulto , Quimiocina CXCL13/genética , Femenino , Factor de Transcripción GATA3/genética , Perfilación de la Expresión Génica , Regulación de la Expresión Génica , Humanos , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Estudios Prospectivos , Proteínas de Dominio T Box/genética , Adulto Joven